RUN vs TIL · P/E 6.0, rev $2.04B vs $51.3M cap
Sunrun Inc (RUN) versus Instil Bio Inc. (TIL) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Instil Bio Inc. (TIL) is a biotechnology company listed on NASDAQ.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
TIL does not have a complete income-statement cache yet.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. TIL currently screens at market cap $51.3M.
Not investment advice. Open the RUN and TIL stock pages for the full models.
Not investment advice.